Emily Willow

Emily Willow is a highly accomplished professional in the field of psychiatry and psychedelic research. As the Founder of InnerPath Health, specializing in ketamine therapy and integrative psychiatry since January 2023, Emily also serves as an Adjunct Professor at the California Institute of Integral Studies and has been a part of the Clinical Research Team and an Independent Clinical Rater for the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2015. Previous roles include Attending Psychiatrist at the University of California, San Francisco, where Emily completed residency training from 2014 to 2018, and a Resident Physician position at the Medical University of South Carolina. Emily holds a Doctor of Medicine (MD) degree from the Medical University of South Carolina and a Bachelor of Science (BS) in Biological and Biomedical Sciences from Clemson University.